UK Housebuilding Sector in 1Q 2020

Hardman & Co

The Promised Land

Red Dwarf, the very British sci-fi comedy franchise, ran for 11 seasons – most recently in 2017; and The Promised Land is a feature-length TV movie – out this year.

Yes, the programme is an acquired taste.

Strangely, too, many episodes are impacted by a virus or three (physiological, not main-frame).

More practical right now, and a veritable Canaan, would be Reverse Flu Virus; and, even better, the Luck Virus.

The former infects the individual with a feeling of well-being and happiness – whilst the latter morphs the host into the luckiest person alive and allows him or her to, very easily, do things which are considered almost impossible.

As the contagion – medical and financial – of COVID-19 spreads, the Red Dwarf viruses would be the ones to have.

But science fiction has an empiric habit of becoming reality.

As a close relative of Red Dwarf once said: “let us think the unthinkable, let us do the undoable, let us prepare to grapple with the ineffable itself, and see if we may not eff it after all”.

DOWNLOAD THE FULL REPORT

Share on:

Latest Company News

Zotefoams acquires US foam manufacturer Verttec for up to $7.3m

Zotefoams has acquired Pennsylvania-based Verttec for up to $7.3m, adding crosslinked technical roll foam manufacturing to its North American operations and expanding its product offering for converter customers.

Drax Group Shares Offer Significant Valuation Upside as Data Centre Opportunity Remains Intact, Says Longspur Research

Drax Group shares offer 47% potential upside according to Longspur Research, with data centre ambitions remaining attractive.

Low market volatility could be masking underlying risks | Ruffer Investment Company

Ruffer's Nicole Wardle explains why record-low stock correlations could be masking US equity market risks, while creating opportunities in overlooked shares and defensive volatility protection.

Bytes Technology Group upgrades guidance after 18% revenue growth

Bytes Technology Group reported an 18.7% increase in first-half revenue to £128.3m, with gross profit up 17.8% to £97.1m. The group upgraded its full-year guidance in September and expects continued growth, supp

Physitrack to publish Q3 2026 results on 20 October

Physitrack PLC will publish its Q3 2026 interim report on 20 October 2026 at 08:00 CET, followed by a webcast at 18:00 CET featuring CEO Henrik Molin and CFO Matt Poulter. Investors will be able to submit questions through Zoom’s Q&A function.

Balfour Beatty sells Gammon Construction stake for £250m

Balfour Beatty has sold its 50% stake in Hong Kong-based Gammon Construction to joint venture partner Jardine Matheson for £250m, supporting its focus on core UK and US markets. The proceeds will be received in three equal tranches, with the first £83.3m payable on completion.

    Search